- Globus Medical’s adjusted earnings per share (EPS) for the fourth quarter is $0.84, surpassing last year’s $0.60 and the estimated $0.75.
- The company’s net sales for the fourth quarter reached $657.3 million, marking a 6.6% increase year-over-year, and exceeded the estimated $643.8 million.
- Globus Medical maintains its full-year 2025 revenue guidance of $2.66 billion to $2.69 billion.
- The forecast for fully diluted non-GAAP earnings per share is between $3.40 and $3.50 for 2025.
- Analyst ratings for Globus Medical include 12 buys, 5 holds, and 0 sells.
Globus Medical Inc A on Smartkarma
Analyst coverage of Globus Medical Inc A on Smartkarma by Baptista Research highlights the company’s strong financial performance in the third quarter of 2024. The report titled “Globus Medical Inc.: An Analysis Of Its International Market Expansion & Other Major Drivers” points to robust growth and successful integration post-merger with NuVasive. Sales of $625.7 million were reported, showing a remarkable 63% increase from the previous year, largely attributed to contributions from the NuVasive acquisition, indicating early merger success.
A look at Globus Medical Inc A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 2 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Smartkarma Smart Scores indicate a positive long-term outlook for Globus Medical Inc A, a medical device company specializing in products for spine disorders. With solid scores in Resilience and Momentum, the company shows strength in weathering market challenges and maintaining upward growth. The company’s focus on innovative fusion technologies positions it well for future growth and success in the medical device industry.
Globus Medical Inc A‘s scores reflect a solid foundation for growth and innovation, with particularly strong Momentum in the market. While the company may have room for improvement in areas like Dividend and Growth scores, its overall outlook appears bright, backed by a strong Resilience score. This suggests that despite challenges, Globus Medical Inc A is well-equipped to navigate the market and continue its trajectory of success in the medical device sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
